PDE2A Rabbit Polyclonal Antibody
cat.: HA500055
| Product Type: | Rabbit polyclonal IgG, primary antibodies |
|---|---|
| Species reactivity: | Human, Mouse |
| Applications: | WB |
| Clonality: | Polyclonal |
| Form: | Liquid |
| Storage condition: | Store at +4℃ after thawing. Aliquot store at -20℃. Avoid repeated freeze / thaw cycles. |
| Storage buffer: | 1*TBS (pH7.4), 0.2% BSA, 50% Glycerol. Preservative: 0.05% Sodium Azide. |
| Concentration: | 1ug/ul |
| Purification: | Protein A affinity purified. |
| Molecular weight: | Predicted band size:105 kDa. |
| Isotype: | IgG |
| Immunogen: | Recombinant protein within human PDE2A aa 750-941. |
| Positive control: | Human brainl tissue lysate, mouse lymphatic tissue lysate. |
| Subcellular location: | Cell membrane, Cytoplasm, Membrane, Mitochondrion, Mitochondrion inner membrane, Mitochondrion outer membrane. |
| Recommended Dilutions:
WB |
1:500-1:1,000 |
| Uniprot #: | SwissProt: O00408 Human | Q922S4 Mouse |
| Alternative names: | 5''-cyclic phosphodiesterase cGMP dependent 3'5' cyclic phosphodiesterase cGMP stimulated phosphodiesterase 1 cGMP stimulated phosphodiesterase 4 cGMP-dependent 3'' cGMP-stimulated phosphodiesterase 2 CGS PDE CGS-PDE cGSPDE Cyclic GMP stimulated phosphodiesterase Cyclic GMP-stimulated phosphodiesterase Human cGMP stimulated 3'5' cyclic nucleotide phosphodiesterase PDE 2A PDE 2A1 PDE 2A4 PDE2A PDE2A_HUMAN PDE2A1 PDE2A4 phosphodiesterase 2A Phosphodiesterase 2A cGMP stimulated |
Images
|
Fig1:
Western blot analysis of PDE2A on different lysates. Proteins were transferred to a PVDF membrane and blocked with 5% BSA in PBS for 1 hour at room temperature. The primary antibody (HA500055, 1/500) was used in 5% BSA at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1:5,000 dilution was used for 1 hour at room temperature. Positive control: Lane 1: Human brainl tissue lysate Lane 2: Mouse lymphatic tissue lysate |
Note: All products are “FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE”.